Phycocyanin-derived bioactive peptide PCP3 ameliorates lipopolysaccharide-induced small intestinal inflammation in murine intestinal organoids and mice through regulating Akt and AMPK/autophagy signaling

Boxiong Wu,Haozhe Cheng,Xinran Li,Qi Yang,Wenjing Zhang,Shuai Hao,Chengtao Wang
DOI: https://doi.org/10.1016/j.fbio.2024.104419
IF: 5.318
2024-08-01
Food Bioscience
Abstract:Phycocyanin, a type of marine-derived food pigment protein, has been reported to exhibit multiple biological functions, while the function of its potential bioactive peptides is rarely investigated. Previously, a novel phycocyanin-derived bioactive peptide (PCP3: MFDAFTK) was identified in our study. The aim of this study was to further explore its anti-inflammatory function of small intestine based on both intestinal organoids and mice models. The results revealed that PCP3 could significantly ameliorate the inflammatory symptoms induced by lipopolysaccharide (LPS), as evidenced by the increased intensity and crypt bud numbers of organoids, the decreased levels of inflammatory factor, the promoted expressions of tight junction and intestinal epithelial cell markers, and the reduced oxidative stress levels of organoids. The in vivo experiments also indicated that PCP3 ameliorated LPS-induced small intestinal inflammation in mice through restoring the physiological form of small intestine, as well as intestinal tight junctions. In addition, pathway analysis suggested that Akt and AMPK/autophagy signaling are involved in the improved process of intestinal inflammation mediated by PCP3. Collectively, this study has laid the foundation for the application of phycocyanin and phycocyanin-derived bioactive peptides in the field of intestinal inflammatory disease, and provides a scientific theoretical basis for the amelioration of intestinal inflammation through functional foods and food derivatives.
food science & technology
What problem does this paper attempt to address?